In this narrative review, we describe the physiological basis for nutritional prehabilitation and evaluate the clinical evidence for its current roles in the perioperative period. Surgical stress and fasting induce insulin resistance as a result of altered mitochondrial function. Insulin resistance in the perioperative period leads to increased morbidity in a dose-dependent fashion, while preoperative carbohydrate loading attenuates insulin resistance, minimises protein loss and improves postoperative muscle function. Carbohydrate loading is an established practice in many countries and a key component of enhanced recovery after surgery (ERAS) programs, yet its independent effects on clinical outcomes remain unclear. Amino acid supplements may confer additional positive effects on a number of markers of clinical outcomes in the perioperative period, but their current role is also poorly defined. Clinical studies evaluating nutritional interventions have been marred by conflicting data, which may be due to small sample sizes, as well as heterogeneity of patients and surgical procedures. At present, it is known that carbohydrate loading is safe and improves patients' wellbeing, but does not appear to influence length of hospital stay or rate of postoperative complications. This should be appreciated before its routine inclusion in ERAS programs.
It has been proposed that preoperative carbohydrate loading, a practice embedded in multimodal enhanced recovery after surgery (ERAS), has a significant independent effect on surgical outcomes 1 . The clinical effects of carbohydrate loading in the perioperative period have been extensively studied and a number of meta-analyses and clinical practice guidelines have been published [2] [3] [4] . Despite consensus guidelines recommending the routine use of preoperative carbohydrate drinks in a number of elective surgical procedures [5] [6] [7] , doubt has now been cast over their clinical benefit and ongoing role in perioperative care 8 . Perhaps less well known are the pathophysiological effects of fasting and surgical trauma and the physiological basis for carbohydrate loading and nutritional interventions, a practice collectively coined 'nutritional prehabilitation'. A sound understanding of these principles may help to identify metabolically vulnerable patients, in whom nutritional interventions may confer greater clinical benefit.
The aim of this narrative review, therefore, is to describe the physiological effects of perioperative fasting, specifically 'routine' fasting and prolonged fasting, as well as the pathophysiology of insulin resistance and context for carbohydrate supplementation. Furthermore, we evaluate the clinical evidence for nutritional prehabilitation and aim to clarify its role in clinical practice.
Methods
A literature search was performed using PubMed, EMBASE, CINAHL and Google Scholar for relevant articles published between 1970 and 2017. The following key words were used: 'ERAS', 'fasting', 'surgical stress', 'insulin resistance', 'immunonutrition' and 'carbohydrate loading'. The search was limited to English language but not restricted to study type. We excluded articles published only in abstract form, and case reports.
Anaesth Intensive Care 2018 | 46:5 and attitudes towards preoperative fasting concurrently changed 10 . 'Modern' fasting guidelines support a more liberal approach and patients are now encouraged to consume clear fluids (water, carbonated drinks, clear tea, black coffee, pulpfree juices) up to two hours before elective surgery 11, 12 . Surgical patients often experience restricted enteral nutrition, such that the total duration of perioperative fasting should be considered, that is the time until normal calorific intake is resumed. Perioperative fasting generates an unfavourable metabolic state, which is additive to that caused by surgical stress, and culminates in insulin resistance 13 . Insulin resistance is a key process in perioperative inflammation and correlates with clinical recovery following surgery 14 . Carbohydrate supplementation is intended to offset unwanted metabolic consequences of fasting and surgical trauma and therefore improve clinical outcomes. (a) Short-term fasting <12 hours During short-term fasting, the liver is the primary source of glucose via glycogenolysis, which provides 4.5 g of glucose per hour. Fasting reduces insulin-mediated glucose uptake into skeletal muscle, slows metabolism and reduces total energy expenditure by 5%-10%. After an overnight fast, most of the body's energy is derived from free fatty acids, but the body continues to consume glucose at a rate of 8-10 g/ hour. In the last few hours of the post-absorptive phase at night, energy expenditure is equal to 75 kcal/hour. During this time, hepatic glycogen is consumed at a linear rate, with most glucose utilised by the brain and other obligate glucose tissues (renal medulla, bone marrow, red blood cells, peripheral nerves) 16 . Glucose utilisation of the brain and red blood cells is 4.5 g/hour and 1.5 g/hour, respectively. Hepatic energy requirements, as well as those of the heart and renal cortex are met by lipolysis of adipose tissue, which provides 5 g of fatty acids per hour. Amino acids are the preferred energy substrate in the intestine 15 .
Metabolic effects of fasting*
As the body transitions to a fed (post-absorptive) state, there is peripheral glucose uptake and glycogen stores are replenished: equating to 50-120 g in the normal adult liver, or up to 10% of liver mass. Importantly, hepatic glycogen is the exclusive endogenous source of glucose; 400 g of glycogen exists in skeletal muscle but is processed for muscle energy alone. At the same time, there is cessation of catabolic processes, including gluconeogenesis, proteolysis and lipolysis. After feeding, a predominantly anabolic state persists for about four hours. The fed state is metabolically superior in the face of stress, including surgery and its attendant catabolic processes. It follows that six hours of preoperative fasting induces peripheral insulin resistance, while clear fluids alone fail to reverse this state of insulin insensitivity. In other words, routine preoperative fasting almost universally generates an unfavourable metabolic condition 17 .
(b) Prolonged fasting-beyond 12 hours
It is nearly 20 years since the American Society of Anesthesiologists (ASA) first published landmark guidelines that abandoned the dogma of 'nil by mouth from midnight' 18 and despite widespread adoption of these guidelines, prolonged fasting before surgery is still commonplace and commonly exceeds 12 hours, especially in emergency surgery 19 . Prolonged fasting leads to a proportional increase in peripheral insulin resistance and hepatic glycogen consumption. The rate of glycogenolysis eventually decreases and becomes non-linear, but hepatic (functional) glycogen stores are virtually depleted after only 18-24 hours, which means there is no readily available energy substrate for critical tissues, notably the nervous system 16 . There is increased reliance on gluconeogenesis and skeletal muscle is sacrificed to generate a pool of amino acids, which is additive to protein loss due to surgical stress. Protein loss occurs in response to increased secretion of glucagon, catecholamines, and cortisol, and the presence of interleukin-1. Increased breakdown of the lean body mass supplies the liver with amino acids to increase glucose production via the alanine-glucose cycle: a pathway of gluconeogenesis. The most common intracellular amino acid is glutamine, which constitutes 50%-60% of the available amino acids within muscle. Glutamine is also a major substrate for renal gluconeogenesis. It is known that glutamine levels in both muscle and plasma acutely decline in critical illness and following major surgery 20 .
There is net destruction of muscle as nitrogen is lost from amino acids during each turn of the alanine-glucose cycle, with ammonia converted to urea. In normal adults, the loss of protein may be as much as 300 g of protein per day during starvation. However, the body rapidly adapts to prolonged fasting and proteolysis is reduced. In fact, after four days there is minimal protein breakdown. Importantly, if sepsis coexists, this adaptive mechanism does not occur and proteolysis inexorably continues. Figure 1 summarises the metabolic effects of continued fasting.
As starvation progresses beyond the first week, the normal post-absorptive basal metabolic rate is reduced from 75 kcal/hour to about 65 kcal/hour in an effort to preserve glucose. By this time, glycogen is long exhausted and protein is significantly depleted. Carbohydrates are no longer the primary energy source; only triglyceride stores are large enough to sustain long-term fasting. Lipolysis of adipose tissue provides 6.6 g of fatty acids per hour and muscle proteolysis provides 1.2 g of amino acids per hour 15 . Starvation contributes to insulin resistance by enhancing lipolysis, which increases fatty acid delivery to muscle tissues. Intramyocellular accumulation of lipid metabolites impairs glucose transporter type 4 (GLUT4) translocation due to defects in insulin signalling caused by phosphorylation of serine residues in Insulin Receptor Substrate-1 21 . In many surgical procedures and postoperative states, enteral intake is not re-established in the immediate postoperative period, and fasting (or a state of low calorific intake) continues for many hours, or even days. Nygren et al emulated a common perioperative scenario by imposing 24 hours of restricted calorific intake (50 g of glucose via intravenous infusion) and demonstrated peripheral insulin resistance in all subjects 22 . Therefore, the total duration of fasting should be taken into account because metabolic derangement is progressive and deleterious effects are added to postoperative catabolism, especially in major surgery.
Importantly, fasting causes dose-dependent peripheral insulin resistance, which is the proposed key event in postoperative inflammation and subsequent clinical recovery. The magnitude of insulin resistance at the time of surgery independently predicts outcome after major surgery 23 , such that the duration of preoperative fasting becomes critically important. From a practical standpoint, it is possible to attenuate perioperative insulin resistance by shortening the duration of fasting, rather than attempting to mitigate surgical stress. This is also the physiological basis of carbohydrate loading: an attainable means of reducing perioperative insulin resistance.
Perioperative insulin resistance
Perioperative fasting and surgical trauma both contribute to perioperative insulin resistance. It has been demonstrated that insulin resistance correlates positively with surgical invasiveness 24, 25 and occurs following even minor surgery, such as laparoscopic cholecystectomy 26 and open inguinal hernia repair 24 . Insulin sensitivity can fall dramatically in the perioperative period and only gradually returns to baseline; Thorell et al showed a 54% decline in mean insulin sensitivity on the first postoperative day following elective upper abdominal surgery using the hyperinsulinaemicnormoglycaemic clamp technique (gold-standard measure) 27 . The authors also demonstrated that insulin resistance persisted for at least five days after the operation and could even take up to three weeks to return to baseline, despite an uncomplicated operative course. Besides surgical magnitude, pain and bed rest independently contribute to perioperative insulin insensitivity 13 . Additional patient characteristics influence the development and magnitude of insulin resistance, including diabetes mellitus, obesity, metabolic syndrome, pregnancy, and starvation 28 . There is also significant inter-individual variation in its natural history, which implies a genetic role in the clinical phenotype.
Crucial from a clinical standpoint, postoperative insulin resistance is implicitly linked to the duration of hospital stay, and its return to baseline coincides with recovery from surgery 14 . Moreover, insulin resistance independently predicts major postoperative morbidity in a dose-dependent fashion 23 . It is likely, therefore, that perioperative insulin resistance is a key process in the pathophysiology of surgical stress, its magnitude and subsequent recovery.
Pathogenesis of insulin resistance in the perioperative period
Insulin resistance can be classified into two subtypes: central and peripheral. Central insulin resistance is characterised by increased hepatic glucose production in the presence of physiological insulin concentrations, while peripheral insulin resistance is characterised by defective skeletal muscle glycogen synthesis, that is, non-oxidative glucose consumption.
Perioperative insulin resistance is associated with diminished circulating insulin-like growth factor-1 (IGF-1) levels and an increase in IGF-binding protein-1 concentrations 17 . IGF-1 is an anabolic hormone with insulinlike effects on glucose and protein metabolism. It is produced primarily in the liver and stimulated by growth hormone. IGFbinding protein-1 inhibits IGF-1 activity. In skeletal muscle cells, there is reduced glycogen synthase activity, which limits glycogenesis. In addition, circulating catecholamines inhibit the binding of insulin to its receptor and sequentially prevents GLUT4 translocation from intracellular vesicles to the muscle membrane 29 . GLUT4 translocation and glucose transport are interrupted, such that skeletal muscle is rendered refractory to the physiological actions of insulin. The net result is peripheral insulin resistance. In this setting, glucose uptake into cells that are normally insensitive to insulin (nerve, renal and blood cells) is permitted and governed by the glucose concentration gradient in plasma and the extracellular space 30 . The development of insulin resistance is also associated with mitochondrial defects. Increased glucose uptake results in excess glycolysis, generating oxygen free radicals in the mitochondria. These oxygen free radicals cause changes in metabolism and gene expression, at the same time promoting cytokine production. Boirie et al found that mitochondrial protein synthesis, mitochondrial enzyme activity and oxidative phosphorylation were all stimulated by insulin 31 . It was suggested that a decrease in insulin concentration during fasting impaired mitochondrial function and oxidative capacity, resulting in an accumulation of intramyocellular lipid which is inversely correlated with muscle insulin sensitivity 32 . Accumulation of these lipid metabolites causes defects in insulin signalling, failure of GLUT4 translocation, and reduced insulin-stimulated glucose uptake 21 .
Relevance of the surgical stress response
Surgery activates a cascade of immune, metabolic, endocrine and autonomic changes, often referred to collectively as the 'stress response' 33 . Postoperative metabolism favours a catabolic state characterised by peripheral insulin resistance, glycogenolysis, enhanced gluconeogenesis, proteolysis, and lipolysis. Counterregulatory hormones (catecholamines, cortisol, growth hormone, glucagon) and pro-inflammatory cytokines are released as part of this process; the end result is hyperglycaemia and loss of nitrogen 34 .
The stress response is initiated by pro-inflammatory cytokines, such as interleukin-1 (IL-1) and tumour necrosis factor (TNF), which are released at the site of surgical trauma by leukocytes and endothelial cells 33 . Interleukin-6 (IL-6) appears to be the main acute phase protein in this process and plasma concentrations have been shown to correlate positively with both magnitude and duration of surgery 35 . Pro-inflammatory cytokines lead to the development of insulin resistance and a compensatory increase in insulin release. Despite this, blood glucose levels increase because of an overriding state of insulin resistance 14 ( Figure 2 ). The magnitude of the stress response also exhibits large interindividual variability, suggesting a genetic component in its pathogenesis 13 . Pro-inflammatory cytokines released during the stress response play an important role in the pathogenesis of perioperative insulin resistance. In the endothelium TNF-α reduces tyrosine phosphorylation and expression of the insulin receptor 36 , while in liver, muscle, and fat cells, it blunts phosphoinositide 3-kinase (PI3K) activation 37 . IL-1 and IL-6 both inhibit insulin-mediated glycogen synthesis 38 . The stress response also leads to abnormal protein metabolism, which can manifest as clinically significant muscle loss. It has been shown that patients undergoing elective open abdominal surgery cumulatively lose 40 to 80 g of nitrogen 39 , while losses from sepsis and burns can be several times higher. Peripheral insulin resistance is a key process in the pathogenesis of proteolysis, resulting primarily from amino acid mobilisation to fuel gluconeogenesis. Amino acids are also mobilised to synthesise acute phase proteins, which are important molecules in postoperative stress. Adverse clinical outcomes include muscle weakness, impaired immune function and delayed wound healing. In fact, loss of lean body mass is directly proportional to the time taken to return to normal physiological function following hospital discharge 34 .
Immune response and clinical implications
The fasted state combined with surgical stress suppresses the immune system. This occurs primarily through atrophy of lymph nodes, a decline in IgA production and inhibition of cellular immunity. T-lymphocytes and natural killer cells are adversely affected by the advent of surgery, ultimately leading to an increased risk of infection for surgical patients 40 . Glutamine, arginine, nucleotides and omega-3 fatty acids are 'immunonutrients' which can positively modulate perioperative immune responses 41 . Glutamine is the most abundant free amino acid in the body and is important for rapidly proliferating cells, including those of the gastrointestinal, central nervous, and immune systems. Glutamine is essential in the body's defence against stress and injury, with roles in immune cell function, glycaemic control, nitrogen balance, gastrointestinal function and attenuation of pro-inflammatory cytokines 20 . Parenteral glutamine supplementation has been shown to reduce insulin resistance 42 , while enteral consumption is safe and does not prolong gastric emptying 43 . Arginine also has important immune effects, enhancing T-cell maturation and activation, while omega-3 fatty acids modify the production of inflammatory mediators including interleukins, cytokines, and eicosanoids 41 . Immunonutrient supplements, including combinations of arginine, glutamine, nucleotides, and omega-3 fatty acids, have all been studied in the perioperative period and, despite a number of published meta-analyses, their clinical role is yet to be defined. A 2017 meta-analysis of more than 7,000 patients undergoing major abdominal surgery concluded that immunonutrition reduces infectious and overall complications and shortens hospital stay by almost two days 44 . However, treatment effects were confounded by low to moderate quality of evidence and a high risk of bias amongst included trials. In fact, in a subgroup analysis, all treatment effects became non-significant when the risk of bias was corrected. A recent review by Gupta and Senagore summarised the difficulties in placing immunonutrients into perioperative care, including a predominance of low-quality evidence, outdated study designs, and uncertain relevance in the era of minimally-invasive surgery and ERAS protocols 45 . They also identify the need for preoperative strategies to better stratify risk with respect to immunonutrient supplementation, including the use of novel imaging techniques and biomarkers to identify malnutrition and sarcopenia. Moving forward, there is still a need for high-quality randomised trials to better define the composition and timing of perioperative immunonutrients, and interrogate methods to enhance risk stratification and patient selection.
Carbohydrate loading
Perioperative carbohydrate loading is now an established strategy to reduce the impact of surgical stress and modulate insulin sensitivity both intraoperatively and postoperatively 46 . Ljungqvist et al postulated that insulin sensitivity can be improved by the ingestion of carbohydrate-rich drinks, although the precise mechanism of action was unclear 47 . More recently, several studies have confirmed that preoperative carbohydrate loading reduces insulin resistance, summarised in Table 1 .
Physiological basis
Carbohydrate loading is provided in the form of carbohydrate-rich drinks consumed in the preoperative period. Studies utilising intravenous glucose infusions at a rate of 5 mg/kg/minute showed a 50% reduction in the development of postoperative insulin resistance in those receiving supplemental carbohydrates 53 . Clinically this equates to a rapid infusion of 20% dextrose solution: sufficient to induce an insulin response, but also causes thrombophlebitis 54 . Commonly used low-concentration glucose solutions, for example 5% dextrose, fail to stimulate insulin release sufficiently to induce a metabolic effect 55 . Sport drinks, typically containing 6%-7% carbohydrates, also fail to stimulate insulin production sufficiently to promote protein-sparing effects 43 . To avoid thrombophlebitis, enteral carbohydrate-rich solutions containing complex carbohydrates were developed.
Oral carbohydrate solutions are iso-osmolar and promote gastric emptying 54 ; 12.5% enteral carbohydrates (50 g in 400 ml) stimulate an insulin response similar to that observed after a meal 17 . The key ingredient is maltodextrin, which is manufactured into a 12.5% high-energy drink, with an osmolality of 135 mOsm/kg. Importantly, it is formulated so that it reliably empties from the stomach after one hour (physiologically behaving as a clear fluid). In a typical ERAS protocol, 800 ml is consumed on the evening before surgery and 400 ml two hours before surgery. The evening dose enhances hepatic glycogen storage but does not preserve perioperative insulin sensitivity. The subsequent morning dose effectively changes the patient from a fasted to fed state, which minimises insulin resistance 56 ( Figure 3 ). Randomised studies of preoperative glucose infusions and carbohydrate-rich beverages reported a 50% reduction in postoperative insulin resistance 57, 58 . 
Cellular effects
Compared to placebo, carbohydrate drinks containing glutamine and antioxidants are associated with a decreased expression of muscle pyruvate dehydrogenase 4 (PDK4) mRNA, PDK4 protein and metallothionein 1A 59 . PDK4 protein inactivates the pyruvate dehydrogenase complex (PDC): a complex of three enzymes that regulates entry of pyruvate (derived from carbohydrate metabolism) into the citric acid cycle. It follows that decreased expression of PDK4 in muscle due to carbohydrate loading sequentially enhances PDC activity and carbohydrate oxidation; the end result is improved insulin sensitivity 60 . Carbohydrate loading also enhances tyrosine kinase and PI3K activity, as well as expression of protein kinase B, all of which are involved in the metabolic actions of insulin and attenuate peripheral insulin resistance 61 . Gianotti et al (2017) demonstrated that oral preoperative carbohydrate loading was an effective method of avoiding perioperative hyperglycaemia in non-diabetic patients (blood glucose >10 mmol/l), as well as reducing the need for insulin, without increasing the incidence of postoperative infection 62 . It has also been shown that glycaemic variability is reduced with preoperative low-dose complex carbohydrate loading in patients undergoing colorectal surgery 63 . Preoperative carbohydrate loading has been shown to be safe in patients with well-controlled type 2 diabetes mellitus. Gustafsson et al (2008) examined the glycaemic effects of a 400 ml carbohydrate-based drink administered three hours before anaesthesia in 25 patients with type 2 diabetes (mean HbA1c 6.2%) and in ten healthy controls. They reported that there was no significant difference in gastric emptying between the diabetic group and control group, and blood glucose levels returned to pre-drink levels within three hours 64 . Poorly-controlled diabetic patients with autonomic neuropathy can have delayed gastric emptying, thus increasing the risk of aspiration 65 .
Glycaemic effects

Perioperative safety
A major concern to anaesthetists is the ingestion of 400 ml of a carbohydrate drink in the immediate preoperative period and a perceived elevated risk of pulmonary aspiration. The half-time of gastric emptying of 500 ml of isotonic saline (a neutral and iso-osmolar inert solution) is 12 minutes; 90% passes through the pylorus within one hour and clearance is nearly complete within two hours. Several studies have demonstrated safe consumption of preoperative carbohydrate drinks, with gastric emptying complete within 90-120 minutes 66, 67 . A scintigraphic study employing a gamma camera showed that gastric emptying of 400 ml of a 12.5% carbohydrate drink was achieved within 90 minutes in both healthy volunteers and in preoperative patients. Before induction of anaesthesia, there was no significant difference in residual gastric volumes compared to placebo 67 . Hausel et al (2001) randomised 252 patients (ASA physical status I and II with no increased baseline risk of pulmonary aspiration) into three groups: fasted overnight, flavoured water (placebo) and carbohydrate loading. The placebo and carbohydrate groups consumed 800 ml of their respective study fluid on the evening prior to surgery and a further 400 ml at least two hours preoperatively. Gastric fluid volumes (GFVs) and pH were measured after induction of anaesthesia (via nasogastric tube aspiration and a single-marker dilution technique). GFVs were small in all groups (fasted median GFV 22 ml; placebo 20 ml; carbohydrate 20 ml). There were no significant differences in GFV between treatment groups. Maximum volumes aspirated were 287 ml in the placebo group, 245 ml in the carbohydrate group and 103 ml in the fasted group. Median gastric pH was 1.9-2.1, with nonsignificant differences between the groups. The authors concluded that administration of a carbohydrate drink two hours before surgery did not increase either GFV or gastric acidity 68 . Studies have also compared preoperative consumption of carbohydrate-based drinks with other types of drinks. A double-blind randomised crossover study in eight patients compared two beverages: Nutricia preOp (Danone, Dublin, Ireland) (beverage A) and a fruit-based lemonade (beverage B) 69 . Gastric emptying (measured by scintigraphy) and hormonal responses were studied, specifically plasma levels of glucose, insulin, C-peptide, glucagon-like peptide (GLP-1; delays gastric emptying and stimulates insulin secretion), peptide YY (PYY; delays gastric emptying), total glucagon and ghrelin (enhances gastric motility and emptying). At two hours post-consumption, the median residual volumes were 0 ml and 48.3 ml for beverages A and B, respectively: a nonsignificant difference. Beverage A emptied from the stomach more rapidly in the first 15 minutes, which may account for the increased plasma levels of glucose, insulin, and C-peptide observed. It is proposed that the rapid emptying of beverage A may be due to its hypo-osmolality; beverage A was specially developed with a higher polysaccharide content, which reduced its osmolality. The non-significant difference in median residual volumes confirmed the findings of previous studies, that is, the concentration rather than type of carbohydrates in the beverage is the principal determinant of gastric emptying 70 . This study also showed that both beverages increased levels of glucose, insulin, C-peptide, GLP-1, glucagon and PYY, while ghrelin levels decreased. Gastric emptying half-time and gastric residual volumes were not correlated with glucose, insulin, total glucagon, PYY or ghrelin. Increased levels of glucose, insulin, and C-peptide indicated an anabolic state arising from consumption of both the carbohydrate-based drink and the fruit-based lemonade.
Clinical effects
Early randomised controlled trials suggested that carbohydrate loading could have an extraordinarily large treatment effect, leading to significant reductions in hospital stay 1 . Subjects given carbohydrate drinks preoperatively were also shown to experience a reduction in postoperative anxiety, thirst, and hunger 68 . Furthermore, in a randomised study of patients undergoing laparoscopic cholecystectomy, the preoperative carbohydrate drink group had a significant reduction in postoperative nausea and vomiting compared with the fasted group 71 . Preoperative carbohydrate drinks also positively modulate muscle strength and maintain muscle mass, with potentially long-lasting effects. In patients receiving carbohydrate loading preoperatively, higher activity in glycogen synthase in the vastus lateralis muscle biopsies were reported up to one month postoperatively 72 . A randomised trial conducted on cardiac surgical patients (ASA physical status III and IV) used exogenous insulin requirement as a marker for postoperative insulin resistance. Whilst it was found that administration of preoperative carbohydrate before cardiac surgery did not influence postoperative insulin resistance, intraoperative inotropic requirements (a tertiary outcome measure) were reduced in the carbohydrate group compared with the placebo or control groups, suggesting improved cardiac performance 73 . Further investigation is required to elucidate whether preoperative carbohydrate administration has clinically significant independent effects on myocardial function.
A randomised study involving 30 patients undergoing orthopaedic procedures investigated the effect of preoperative carbohydrates on the immune system 58 . Patients were randomised into three groups: two groups received carbohydrate-rich drinks preoperatively (Beverage A: Nutricia preOp and Beverage B: diluted fruit-based syrup) while the third group fasted overnight. Human leukocyte antigen (HLA)-DR expression on monocytes was measured the day prior to surgery and the day after surgery. HLA-DR is required for antigen presentation and reduced expression of HLA-DR is linked to an increased risk of postoperative . However, these meta-analyses did not account for different doses of carbohydrates administered or different control methods used. A more recent network (multiple treatments comparisons) meta-analysis of 43 trials (3,110 subjects), concluded that preoperative carbohydrate loading before elective surgery resulted in a small reduction in length of stay compared with fasting, but not compared with water or placebo 8 . There was no significant difference in the postoperative complication rates for patients receiving a carbohydrate load compared with patients who fasted or those who received water or a placebo drink. There was moderate statistical heterogeneity and inconsistencies for some outcomes due to the differences in trial design, outcome measures and clinical settings. Table 2 summarises the main findings of meta-analyses comparing carbohydrate loading with control.
A consistent theme in these meta-analyses is that the quality of evidence is low to moderate for virtually all outcomes. Furthermore, data on the clinical effects, such as length of stay and rates of complications, are conflicting due to a small number of trials and small sample sizes, as well as heterogeneity of patients and type of surgery. Administration of oral carbohydrate drinks two hours preoperatively is safe and has been embedded in ERAS protocols, albeit without strong evidence to support an independent effect on clinical outcomes. The evidence overall indicates that carbohydrate loading fails to influence either length of stay or complication rates after surgery, provided that patients are permitted to consume clear fluids in the preoperative period. This finding reinforces the importance of adhering to modern fasting guidelines and the move away from the practice of 'nil by mouth from midnight'. We also agree that the economic implications of these drinks should be considered before their routine administration and uncontested inclusion in ERAS programs 8 .
Conclusion
The strength of this review is that it revisits the basic science behind nutritional prehabilitation, which enables the reader to anticipate the burden of perioperative insulin resistance and, at the same time, identify patient groups that might benefit most from nutritional supplements. We also emphasise the value of simple interventions that mitigate insulin resistance, including minimising the duration of preoperative fasting, providing effective analgesia and promoting early postoperative enteral intake and mobilisation: key tenets of ERAS.
There remains much scope for rigorously designed or multicentre trials to better define the role of carbohydrate loading in the perioperative period. Future studies should also investigate the effects of supplemental immunonutrients and metabolic conditioning agents such as glutamine and citrulline.
